Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.

Autor: Jin, Hua1 (AUTHOR), Zhang, Yu1 (AUTHOR), Yu, Sijian1 (AUTHOR), Du, Xin2 (AUTHOR), Xu, Na1 (AUTHOR), Shao, Ruoyang1 (AUTHOR), Lin, Dongjun3 (AUTHOR), Chen, Yanqiu1,4 (AUTHOR), Xiao, Jie5 (AUTHOR), Sun, Zhiqiang6 (AUTHOR), Deng, Lan7 (AUTHOR), Liang, Xinquan8 (AUTHOR), Zhang, Hongyu9 (AUTHOR), Guo, Ziwen10 (AUTHOR), Dai, Min1 (AUTHOR), Shi, Pengcheng1 (AUTHOR), Huang, Fen1 (AUTHOR), Fan, Zhiping1 (AUTHOR), Yin, Zhao1 (AUTHOR), Xuan, Li1 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 4/29/2023, Vol. 16 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje